Remarkably, the small molecule YK-4-279 effectively inhibited ERG- and ETV1-driven transcriptional activity, leading to decreased cell motility and invasion [84] and reduced primary tumor growth and metastasis of fusion-positive PC xenografts [85]. The gene discussed is ERG; the disease is neoplasm.